Skip to content

Investigating the effect of topical use of fenugreek seeds on the outcomes of osteoarthritis in the elderly

Investigating the effect of topical use of fenugreek seeds on the outcomes of osteoarthritis in the elderly

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100124003146N13
Enrollment
32
Registered
2024-08-25
Start date
2024-08-30
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: In this study, fenugreek extract prepared in hydroalcoholic form will be purchased by Asha Organic Company and will be prepared by a pharmacist with 2.5% plain sani

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Have osteoarthritis as confirmed by a rheumatology doctor. Age 60 and above. Not having a history of allergy to products such as turmeric, thyme, vaseline, etc. Willingness to participate in the study. able to answer the questionnaire questions. No history of surgery, injury and fall in the knee at least in the last three months No signs of active infection in the knee area Do not have known mental disorders (self-reported or accompanied). not having mental disorders (based on the score obtained from the short mental state test)

Exclusion criteria

Exclusion criteria: Those who do not use fenugreek seed extract for more than one week continuously. Samples become unavailable during the study The occurrence of allergic problems in the area or as a result of taking this medicine Hospitalization, death, surgery, fall, knee injury Injection in the knee during the intervention

Design outcomes

Primary

MeasureTime frame
Outcome of osteoarthritis. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention (30 days), one month after the end of the intervention. Method of measurement: Rheumatoid and Arthritis Outcome Score.

Secondary

MeasureTime frame
Anxiety. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention, one month after the end of the intervention. Method of measurement: Beck Anxiety Inventory.;Sleep quality. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention, one month after the end of the intervention. Method of measurement: Pittsburgh Sleep Quality Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIsmail Azizi-Fini

Kashan University of Medical Sciences

azizifinies@yahoo.com+98 36 155103136

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026